GR3036865T3 - Improved in vitro method, kits and reagents for screening for blood coagulation defects - Google Patents

Improved in vitro method, kits and reagents for screening for blood coagulation defects

Info

Publication number
GR3036865T3
GR3036865T3 GR20010401728T GR20010401728T GR3036865T3 GR 3036865 T3 GR3036865 T3 GR 3036865T3 GR 20010401728 T GR20010401728 T GR 20010401728T GR 20010401728 T GR20010401728 T GR 20010401728T GR 3036865 T3 GR3036865 T3 GR 3036865T3
Authority
GR
Greece
Prior art keywords
coagulation
kits
reagents
conversion rate
screening
Prior art date
Application number
GR20010401728T
Other languages
Greek (el)
English (en)
Inventor
Bert Steffen Rosen
Christina Maria Yvonne Hall
Original Assignee
Chromogenix Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chromogenix Ab filed Critical Chromogenix Ab
Publication of GR3036865T3 publication Critical patent/GR3036865T3/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GR20010401728T 1998-03-19 2001-10-11 Improved in vitro method, kits and reagents for screening for blood coagulation defects GR3036865T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98105043A EP0947585B1 (fr) 1998-03-19 1998-03-19 Méthodes, trousses et réactifs améliorés pour le criblage de défauts de la coagulation sanguine

Publications (1)

Publication Number Publication Date
GR3036865T3 true GR3036865T3 (en) 2002-01-31

Family

ID=8231624

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401728T GR3036865T3 (en) 1998-03-19 2001-10-11 Improved in vitro method, kits and reagents for screening for blood coagulation defects

Country Status (12)

Country Link
US (4) US6395501B1 (fr)
EP (1) EP0947585B1 (fr)
AT (1) ATE203567T1 (fr)
AU (2) AU758831B2 (fr)
CA (1) CA2334935C (fr)
DE (1) DE69801210T2 (fr)
DK (1) DK0947585T3 (fr)
ES (1) ES2162361T3 (fr)
GR (1) GR3036865T3 (fr)
NZ (1) NZ506747A (fr)
PT (1) PT947585E (fr)
WO (1) WO1999047699A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429017B1 (en) * 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
DE69801210T2 (de) * 1998-03-19 2002-05-02 Instrumentation Laboratory S.P.A., Mailand/Milano Verbesserte in vitro Verfahren, Testkits und Reagenzien zum Screening von Blutgerinnungsfehlern
ES2231167T3 (es) 1999-02-04 2005-05-16 Biomerieux, Inc. Procedimiento y aparato para predecir la disfuncion hemostatica en una muestra de un paciente.
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
EP1260817A3 (fr) 2001-05-08 2002-12-18 Warner-Lambert Company Procédé de mesure directe du facteur de coagulation VIIa dans du plasma
JP2004535461A (ja) * 2001-07-19 2004-11-25 ディーエムアイ バイオサイエンシズ インコーポレイテッド プロテインｃの不活性化を抑制するための銅キレート剤の使用
US6902904B2 (en) * 2001-08-27 2005-06-07 Pharmanetics Incorporated Coagulation assay reagents containing lanthanides
EP1367135A1 (fr) * 2002-05-29 2003-12-03 Pentapharm AG Procédé amélioré pour l'évaluation de formation de thrombin dans plasma sanguine
US20040091952A1 (en) * 2002-07-25 2004-05-13 Sysmex Corporation Reagent kit for detecting lupus anticoagulant
WO2005031303A2 (fr) * 2003-09-22 2005-04-07 University Of North Carolina At Chapel Hill Phospholipides solubles a utiliser dans des analyses du facteur de coagulation
DE602005006633D1 (de) * 2004-02-06 2008-06-26 Sysmex Corp Reagenziensatz zum Nachweis von Lupus-Antikoagulant.
ES2357112T3 (es) * 2005-01-07 2011-04-18 Stichting Katholieke Universiteit Ensayo de hemostasia.
JP4639904B2 (ja) * 2005-03-30 2011-02-23 チッソ株式会社 蛍光活性を有するルシフェラーゼの活性増強方法
JP4609177B2 (ja) * 2005-04-28 2011-01-12 チッソ株式会社 カルシウム結合型発光蛋白質溶液の発光時間延長方法
US7957521B2 (en) * 2005-11-30 2011-06-07 On-Q Telecom Systems Co., Inc. Method and system for user prioritization within telecommunication services and in particular within call completion services
FR2908892B1 (fr) * 2006-11-21 2009-02-20 Hyphen Biomed Soc Par Actions Procede pour le dosage chromogenique de l'activite du facteur viii:c et necessaire de dosage chromogenique de l'activite du facteur viii:c,dans les plasmas ou les fractions therapeutiques
FR2909180B1 (fr) * 2006-11-29 2009-02-20 Diagnostica Stago Soc Par Acti Methode de mesure fonctionnelle de l'activite de la thrombomoduline plasmatique.
WO2010016762A1 (fr) * 2008-08-05 2010-02-11 Synapse B.V. Méthode et ensemble pour mesurer une génération de thrombine dans du plasma
US9057574B2 (en) 2012-06-14 2015-06-16 Ra Brands, L.L.C. Thumb safety for model 1911 handgun
JP6595247B2 (ja) * 2015-07-30 2019-10-23 シスメックス株式会社 凝固時間の測定方法およびその装置、凝固時間測定用試薬ならびに試薬キット
JP6577778B2 (ja) * 2015-07-30 2019-09-18 シスメックス株式会社 凝固時間の測定方法およびその装置、凝固時間測定用試薬ならびに試薬キット
CN110568117B (zh) * 2019-09-19 2022-03-22 青岛海洋生物医药研究院股份有限公司 一种多靶点抗血栓活性物质的液相色谱-质谱筛选方法
CN111707837A (zh) * 2020-05-29 2020-09-25 上海太阳生物技术有限公司 狼疮抗凝物确认试剂盒（凝固法）

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE203509C (fr) *
DE3607559A1 (de) * 1986-03-07 1987-09-10 Boehringer Mannheim Gmbh Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet
US5055412A (en) * 1989-03-21 1991-10-08 Proksch Gary J Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same
SE464135B (sv) * 1989-07-14 1991-03-11 Kabivitrum Ab Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5308756A (en) * 1991-11-20 1994-05-03 Baxter Diagnostics Inc. Protein S chromogenic assay
US5637452A (en) * 1992-10-02 1997-06-10 Analytical Control Systems, Inc. Kit for an initial screen for abnormal platelet condition comprising propyl gallate or tannin and a metal ion
DE4402631A1 (de) * 1994-01-29 1995-08-03 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Gerinnungsparametern
ATE200225T1 (de) * 1994-04-22 2001-04-15 Sanquin Bloedvoorziening Mittel für die behandlung von störungen des blutgerinnungsprozess
DE59812615D1 (de) * 1997-04-25 2005-04-07 Pentapharm Ag Basel Verfahren zum funktionellen nachweis von störungen im protein c-system
DE19749197A1 (de) * 1997-11-07 1999-05-12 Dade Behring Marburg Gmbh Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe
AUPP159698A0 (en) * 1998-02-02 1998-02-26 Life Therapeutics Limited Improved blood coagulation test
US6245573B1 (en) * 1998-02-12 2001-06-12 University Of Medicine And Dentistry Of New Jersey Rapid assessment of the coagulant activity of blood
DE69801210T2 (de) 1998-03-19 2002-05-02 Instrumentation Laboratory S.P.A., Mailand/Milano Verbesserte in vitro Verfahren, Testkits und Reagenzien zum Screening von Blutgerinnungsfehlern
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
AU2002235073B2 (en) * 2001-03-02 2007-02-01 T.A.C. Thrombosis And Coagulation Ab Protein C variants
US6902904B2 (en) * 2001-08-27 2005-06-07 Pharmanetics Incorporated Coagulation assay reagents containing lanthanides

Also Published As

Publication number Publication date
AU2003212064A1 (en) 2003-08-14
US20040235078A1 (en) 2004-11-25
AU2003212064B9 (en) 2005-11-24
US20020115127A1 (en) 2002-08-22
AU3033999A (en) 1999-10-11
ES2162361T3 (es) 2001-12-16
US6395501B1 (en) 2002-05-28
DK0947585T3 (da) 2001-10-01
AU758831B2 (en) 2003-04-03
US6800450B2 (en) 2004-10-05
CA2334935C (fr) 2009-10-13
EP0947585A1 (fr) 1999-10-06
WO1999047699A1 (fr) 1999-09-23
US6730490B2 (en) 2004-05-04
AU2003212064B2 (en) 2005-10-20
EP0947585B1 (fr) 2001-07-25
ATE203567T1 (de) 2001-08-15
DE69801210T2 (de) 2002-05-02
DE69801210D1 (de) 2001-08-30
NZ506747A (en) 2003-03-28
CA2334935A1 (fr) 1999-09-23
PT947585E (pt) 2001-11-30
US7118880B2 (en) 2006-10-10
US20030199014A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
GR3036865T3 (en) Improved in vitro method, kits and reagents for screening for blood coagulation defects
ES2084061T3 (es) Composicion y procedimiento de ensayo de cuerpos cetonicos.
EP1234053A4 (fr) Appareil et procede pour faire des dosages de coagulation dans des echantillons liquides
DK314987A (da) Fremgangsmaade til specifik bestemmelse af serumfructosaminindhold samt hertil egnet reagensblanding
AU4849085A (en) Screening test for reverse-transcriptase containing virus
BR9406223A (pt) Método para determinar em uma amostra a atividade funcional de um componente da coagulação sanguinea método para diagnosticar um disturbio da coagulação/anticoagulação sanguinea preparado de anticorpo linhagem celular uso de fator v subunidades ou fragmentos do mesmo tendo atividade anticoagulante na forma de cofator par apc prepraro de plasma embalado plasma deficiente em atividade anticoagulante de fator v como cofator para apc uso do preparado de anticorpo preparado de proteina s preparado de
CA2162531A1 (fr) Methode pour la detection specifique d'un facteur de coagulation v qui possede une plus grande stabilite vis-a-vis de la proteine c activee
EA199800493A1 (ru) Анализ крови на соотношение активности фактора v для оценки вероятности заболевания тромбоэмболией
CA2002208A1 (fr) Methodes d'extraction pour preparer des reactifs de thromboplastine
DK484682A (da) Fremgangsmaade til kvantitativ bestemmelse af blodkoagulationsfaktor xii i humant plasma
CA2283154A1 (fr) Methode et dispositif pour doser des succedanes du sang
WO2002012892A3 (fr) Panneaux multiples rapides de biomarqueurs des ait/avc dans des analyses sanguines en laboratoire
DE69808930D1 (de) Leberfunktionstest
De Nicola Analytical Review: Factor VII (SPCA): Its Physiopathologic Significance
CA2019872A1 (fr) Methode et trousse pour la mesure de l'activite fonctionnelle de la proteine s dans le plasma humain
DK0587090T3 (da) Fremgangsmåde til bestemmelse af thromboseforårsagende lupus-antikoagulat-antistoffer.
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
Hucker et al. Evaluation of enzymic assay for paracetamol: Clinical and forensic experiences
RU98116219A (ru) Способ определения состояния печени субъекта и набор для анализа
EP4682903A3 (fr) Système d'aide à la décision clinique
ATE200710T1 (de) Verfahren zur diagnose von blutgerinnungsstörungen
HUT53229A (en) Process for radioimmunological determination of 3'-azido-3'-deoxythymidine content of biological samples
PT788595E (pt) Metodo de teste da competencia imunologica
ES2104476T3 (es) Ensayo para determinar el glaucoma de angulo abierto primario (gaap) por analisis de la actividad de la 3-alfa-hidroxiesteroide-deshidrogenasa de las celulas sanguineas perifericas y kit para realizar el citado ensayo.
RU93048478A (ru) Способ определения содержания глюкозы в сыворотке крови

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees